Anti-Inflammatory Analgesic and Antipyretic Drug can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.
The global market for Anti-Inflammatory Analgesic and Antipyretic Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Anti-Inflammatory Analgesic and Antipyretic Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Anti-Inflammatory Analgesic and Antipyretic Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Anti-Inflammatory Analgesic and Antipyretic Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Anti-Inflammatory Analgesic and Antipyretic Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Anti-Inflammatory Analgesic and Antipyretic Drugs players cover Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl and BASF, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Anti-Inflammatory Analgesic and Antipyretic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Anti-Inflammatory Analgesic and Antipyretic Drugs market, with both quantitative and qualitative data, to help readers understand how the Anti-Inflammatory Analgesic and Antipyretic Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Anti-Inflammatory Analgesic and Antipyretic Drugs market and forecasts the market size by Type (Paracetamol, Aspirin and Ibuprofen), by Application (Adults and Children.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others
Segmentation by application
Adults
Children
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF
Lu'an Pharmaceutical
Mallinckrodt
Farmson
Anhui Fubore
SKPL
Atabay
Huzhou Konch Pharmaceutical
Anhui Topsun
SOLARA
SI Group
Chapter Introduction
Chapter 1: Scope of Anti-Inflammatory Analgesic and Antipyretic Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Anti-Inflammatory Analgesic and Antipyretic Drugs market size (sales and revenue) and CAGR, Anti-Inflammatory Analgesic and Antipyretic Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Anti-Inflammatory Analgesic and Antipyretic Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Anti-Inflammatory Analgesic and Antipyretic Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Anti-Inflammatory Analgesic and Antipyretic Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm and Granules India Limited, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Anti-Inflammatory Analgesic and Antipyretic Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Anti-Inflammatory Analgesic and Antipyretic Drugs by Country/Region, 2017, 2022 & 2028
2.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Type
2.2.1 Paracetamol
2.2.2 Aspirin
2.2.3 Ibuprofen
2.2.4 Naproxen
2.2.5 Diclofenac
2.2.6 Oxaprozin
2.2.7 Dexibuprofen
2.2.8 Others
2.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type
2.3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Price by Type (2017-2022)
2.4 Anti-Inflammatory Analgesic and Antipyretic Drugs Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application
2.5.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Price by Application (2017-2022)
3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs by Company
3.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Breakdown Data by Company
3.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Company (2020-2022)
3.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Company (2020-2022)
3.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Price by Company
3.4 Key Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Product Location Distribution
3.4.2 Players Anti-Inflammatory Analgesic and Antipyretic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-Inflammatory Analgesic and Antipyretic Drugs by Geographic Region
4.1 World Historic Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Revenue by Geographic Region
4.2 World Historic Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Revenue by Country/Region
4.3 Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Growth
4.4 APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Growth
4.5 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Growth
4.6 Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Growth
5 Americas
5.1 Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country
5.1.1 Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2022)
5.1.2 Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2022)
5.2 Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type
5.3 Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region
6.1.1 APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2017-2022)
6.1.2 APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2017-2022)
6.2 APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type
6.3 APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs by Country
7.1.1 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2022)
7.1.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2022)
7.2 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type
7.3 Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs by Country
8.1.1 Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type
8.3 Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs
10.3 Manufacturing Process Analysis of Anti-Inflammatory Analgesic and Antipyretic Drugs
10.4 Industry Chain Structure of Anti-Inflammatory Analgesic and Antipyretic Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors
11.3 Anti-Inflammatory Analgesic and Antipyretic Drugs Customer
12 World Forecast Review for Anti-Inflammatory Analgesic and Antipyretic Drugs by Geographic Region
12.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Market Size Forecast by Region
12.1.1 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecast by Region (2023-2028)
12.1.2 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecast by Type
12.7 Global Anti-Inflammatory Analgesic and Antipyretic Drugs Forecast by Application
13 Key Players Analysis
13.1 Mallinckrodt Pharmaceuticals
13.1.1 Mallinckrodt Pharmaceuticals Company Information
13.1.2 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.1.3 Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.1.5 Mallinckrodt Pharmaceuticals Latest Developments
13.2 IOL
13.2.1 IOL Company Information
13.2.2 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.2.3 IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 IOL Main Business Overview
13.2.5 IOL Latest Developments
13.3 Anqiu Lu'an Pharmaceutical
13.3.1 Anqiu Lu'an Pharmaceutical Company Information
13.3.2 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.3.3 Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Anqiu Lu'an Pharmaceutical Main Business Overview
13.3.5 Anqiu Lu'an Pharmaceutical Latest Developments
13.4 Novacyl
13.4.1 Novacyl Company Information
13.4.2 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.4.3 Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novacyl Main Business Overview
13.4.5 Novacyl Latest Developments
13.5 BASF
13.5.1 BASF Company Information
13.5.2 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.5.3 BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 BASF Main Business Overview
13.5.5 BASF Latest Developments
13.6 Anhui BBCA Pharmaceuticals
13.6.1 Anhui BBCA Pharmaceuticals Company Information
13.6.2 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.6.3 Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Anhui BBCA Pharmaceuticals Main Business Overview
13.6.5 Anhui BBCA Pharmaceuticals Latest Developments
13.7 Hubei Biocause
13.7.1 Hubei Biocause Company Information
13.7.2 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.7.3 Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hubei Biocause Main Business Overview
13.7.5 Hubei Biocause Latest Developments
13.8 Xinhua Pharm
13.8.1 Xinhua Pharm Company Information
13.8.2 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.8.3 Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Xinhua Pharm Main Business Overview
13.8.5 Xinhua Pharm Latest Developments
13.9 Granules India Limited
13.9.1 Granules India Limited Company Information
13.9.2 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.9.3 Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Granules India Limited Main Business Overview
13.9.5 Granules India Limited Latest Developments
13.10 Huagang Pharm
13.10.1 Huagang Pharm Company Information
13.10.2 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.10.3 Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Huagang Pharm Main Business Overview
13.10.5 Huagang Pharm Latest Developments
13.11 Hebei Jiheng Pharmaceutical
13.11.1 Hebei Jiheng Pharmaceutical Company Information
13.11.2 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.11.3 Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hebei Jiheng Pharmaceutical Main Business Overview
13.11.5 Hebei Jiheng Pharmaceutical Latest Developments
13.12 Zhejiang Kangle Pharmaceutical
13.12.1 Zhejiang Kangle Pharmaceutical Company Information
13.12.2 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.12.3 Zhejiang Kangle Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zhejiang Kangle Pharmaceutical Main Business Overview
13.12.5 Zhejiang Kangle Pharmaceutical Latest Developments
13.13 Hebei Jingye Medical Technology
13.13.1 Hebei Jingye Medical Technology Company Information
13.13.2 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.13.3 Hebei Jingye Medical Technology Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hebei Jingye Medical Technology Main Business Overview
13.13.5 Hebei Jingye Medical Technology Latest Developments
13.14 MSPF
13.14.1 MSPF Company Information
13.14.2 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.14.3 MSPF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 MSPF Main Business Overview
13.14.5 MSPF Latest Developments
13.15 Lu'an Pharmaceutical
13.15.1 Lu'an Pharmaceutical Company Information
13.15.2 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.15.3 Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Lu'an Pharmaceutical Main Business Overview
13.15.5 Lu'an Pharmaceutical Latest Developments
13.16 Mallinckrodt
13.16.1 Mallinckrodt Company Information
13.16.2 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.16.3 Mallinckrodt Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Mallinckrodt Main Business Overview
13.16.5 Mallinckrodt Latest Developments
13.17 Farmson
13.17.1 Farmson Company Information
13.17.2 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.17.3 Farmson Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Farmson Main Business Overview
13.17.5 Farmson Latest Developments
13.18 Anhui Fubore
13.18.1 Anhui Fubore Company Information
13.18.2 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.18.3 Anhui Fubore Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Anhui Fubore Main Business Overview
13.18.5 Anhui Fubore Latest Developments
13.19 SKPL
13.19.1 SKPL Company Information
13.19.2 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.19.3 SKPL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 SKPL Main Business Overview
13.19.5 SKPL Latest Developments
13.20 Atabay
13.20.1 Atabay Company Information
13.20.2 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.20.3 Atabay Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Atabay Main Business Overview
13.20.5 Atabay Latest Developments
13.21 Huzhou Konch Pharmaceutical
13.21.1 Huzhou Konch Pharmaceutical Company Information
13.21.2 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.21.3 Huzhou Konch Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Huzhou Konch Pharmaceutical Main Business Overview
13.21.5 Huzhou Konch Pharmaceutical Latest Developments
13.22 Anhui Topsun
13.22.1 Anhui Topsun Company Information
13.22.2 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.22.3 Anhui Topsun Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Anhui Topsun Main Business Overview
13.22.5 Anhui Topsun Latest Developments
13.23 SOLARA
13.23.1 SOLARA Company Information
13.23.2 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.23.3 SOLARA Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 SOLARA Main Business Overview
13.23.5 SOLARA Latest Developments
13.24 SI Group
13.24.1 SI Group Company Information
13.24.2 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
13.24.3 SI Group Anti-Inflammatory Analgesic and Antipyretic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 SI Group Main Business Overview
13.24.5 SI Group Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Anti-Inflammatory Analgesic and Antipyretic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Paracetamol
Table 4. Major Players of Aspirin
Table 5. Major Players of Ibuprofen
Table 6. Major Players of Naproxen
Table 7. Major Players of Diclofenac
Table 8. Major Players of Oxaprozin
Table 9. Major Players of Dexibuprofen
Table 10. Major Players of Others
Table 11. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2022) & (Tons)
Table 12. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2022)
Table 13. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Type (2017-2022) & ($ million)
Table 14. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Type (2017-2022)
Table 15. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Price by Type (2017-2022) & (US$/Ton)
Table 16. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2022) & (Tons)
Table 17. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2017-2022)
Table 18. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Application (2017-2022)
Table 19. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Application (2017-2022)
Table 20. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Price by Application (2017-2022) & (US$/Ton)
Table 21. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Company (2020-2022) & (Tons)
Table 22. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Company (2020-2022)
Table 23. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Company (2020-2022) ($ Millions)
Table 24. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Company (2020-2022)
Table 25. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sale Price by Company (2020-2022) & (US$/Ton)
Table 26. Key Manufacturers Anti-Inflammatory Analgesic and Antipyretic Drugs Producing Area Distribution and Sales Area
Table 27. Players Anti-Inflammatory Analgesic and Antipyretic Drugs Products Offered
Table 28. Anti-Inflammatory Analgesic and Antipyretic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Geographic Region (2017-2022) & (Tons)
Table 32. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share Geographic Region (2017-2022)
Table 33. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 34. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 35. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country/Region (2017-2022) & (Tons)
Table 36. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country/Region (2017-2022)
Table 37. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 38. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country/Region (2017-2022)
Table 39. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2022) & (Tons)
Table 40. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2017-2022)
Table 41. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 42. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2017-2022)
Table 43. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2022) & (Tons)
Table 44. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2022)
Table 45. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2022) & (Tons)
Table 46. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2017-2022)
Table 47. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Region (2017-2022) & (Tons)
Table 48. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Region (2017-2022)
Table 49. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 50. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Region (2017-2022)
Table 51. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2022) & (Tons)
Table 52. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2022)
Table 53. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2022) & (Tons)
Table 54. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2017-2022)
Table 55. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2022) & (Tons)
Table 56. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2017-2022)
Table 57. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 58. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2017-2022)
Table 59. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2022) & (Tons)
Table 60. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2022)
Table 61. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2022) & (Tons)
Table 62. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2017-2022)
Table 63. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Country (2017-2022) & (Tons)
Table 64. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Country (2017-2022)
Table 65. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 66. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share by Country (2017-2022)
Table 67. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Type (2017-2022) & (Tons)
Table 68. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Type (2017-2022)
Table 69. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales by Application (2017-2022) & (Tons)
Table 70. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share by Application (2017-2022)
Table 71. Key Market Drivers & Growth Opportunities of Anti-Inflammatory Analgesic and Antipyretic Drugs
Table 72. Key Market Challenges & Risks of Anti-Inflammatory Analgesic and Antipyretic Drugs
Table 73. Key Industry Trends of Anti-Inflammatory Analgesic and Antipyretic Drugs
Table 74. Anti-Inflammatory Analgesic and Antipyretic Drugs Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Anti-Inflammatory Analgesic and Antipyretic Drugs Distributors List
Table 77. Anti-Inflammatory Analgesic and Antipyretic Drugs Customer List
Table 78. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Region (2023-2028) & (Tons)
Table 79. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Forecast by Region
Table 80. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 82. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Americas Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Region (2023-2028) & (Tons)
Table 85. APAC Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 86. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Country (2023-2028) & (Tons)
Table 87. Europe Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Country (2023-2028) & (Tons)
Table 89. Middle East & Africa Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 90. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Type (2023-2028) & (Tons)
Table 91. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share Forecast by Type (2023-2028)
Table 92. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 93. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 94. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Forecast by Application (2023-2028) & (Tons)
Table 95. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Sales Market Share Forecast by Application (2023-2028)
Table 96. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 97. Global Anti-Inflammatory Analgesic and Antipyretic Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 98. Mallinckrodt Pharmaceuticals Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 100. Mallinckrodt Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 101. Mallinckrodt Pharmaceuticals Main Business
Table 102. Mallinckrodt Pharmaceuticals Latest Developments
Table 103. IOL Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 105. IOL Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 106. IOL Main Business
Table 107. IOL Latest Developments
Table 108. Anqiu Lu'an Pharmaceutical Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 110. Anqiu Lu'an Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 111. Anqiu Lu'an Pharmaceutical Main Business
Table 112. Anqiu Lu'an Pharmaceutical Latest Developments
Table 113. Novacyl Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 115. Novacyl Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 116. Novacyl Main Business
Table 117. Novacyl Latest Developments
Table 118. BASF Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 120. BASF Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 121. BASF Main Business
Table 122. BASF Latest Developments
Table 123. Anhui BBCA Pharmaceuticals Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 125. Anhui BBCA Pharmaceuticals Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 126. Anhui BBCA Pharmaceuticals Main Business
Table 127. Anhui BBCA Pharmaceuticals Latest Developments
Table 128. Hubei Biocause Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 130. Hubei Biocause Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 131. Hubei Biocause Main Business
Table 132. Hubei Biocause Latest Developments
Table 133. Xinhua Pharm Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 135. Xinhua Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 136. Xinhua Pharm Main Business
Table 137. Xinhua Pharm Latest Developments
Table 138. Granules India Limited Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 140. Granules India Limited Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 141. Granules India Limited Main Business
Table 142. Granules India Limited Latest Developments
Table 143. Huagang Pharm Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 145. Huagang Pharm Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 146. Huagang Pharm Main Business
Table 147. Huagang Pharm Latest Developments
Table 148. Hebei Jiheng Pharmaceutical Basic Information, Anti-Inflammatory Analgesic and Antipyretic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Product Offered
Table 150. Hebei Jiheng Pharmaceutical Anti-Inflammatory Analgesic and Antipyretic Drugs Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 151. Hebei Jiheng Pharmaceutical Main Business
Table 152. Hebei Jiheng Pharmaceutical Latest Developments
Table 153. Zhejiang Kangle